FORM 4
☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Sveen Christopher D.		 2. Issuer Name and Ticker or Trading Symbol

HESKA CORP [ HSKA ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
CAO & General Counsel
(Last)          (First)          (Middle)

3760 ROCKY MOUNTAIN AVENUE		 3. Date of Earliest Transaction (MM/DD/YYYY)

2/28/2022
(Street)

LOVELAND, CO 80538		 4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)        (State)        (Zip)
Rule 10b5-1(c) Transaction Indication
☐ Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 6/13/2023  A(1)  15157 A$0 23643 D  
Common Stock 6/13/2023  A(2)  3948 A$0 27591 D  
Common Stock 6/13/2023  D(3)  27591 D$120 0 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance Shares  (4)6/13/2023  D     750   (4)3/31/2025 Common Stock 750  (4)0 (5)D  
Non-Qualified Stock Option (right to buy) $60.94 2/28/2022  A (6)  10000    2/28/2022 4/15/2030 Common Stock 10000 $0 10000 D  
Non-Qualified Stock Option (right to buy) $60.94 6/13/2023  A (7)  25000    6/13/2023 4/15/2030 Common Stock 25000 $0 35000 D  
Non-Qualified Stock Option (right to buy) $60.94 6/13/2023  D     35000   (6)(7)4/15/2030 Common Stock 35000  (8)0 D  
Incentive Stock Option (right to buy) $60.94 6/13/2023  D     2   (9)4/15/2030 Common Stock 2  (8)0 D  
Non-Qualified Stock Option (right to buy) $60.94 6/13/2023  D     9998   (9)4/15/2030 Common Stock 9998  (8)0 D  
Incentive Stock Option (right to buy) $71.84 6/13/2023  D     4173   (10)9/23/2029 Common Stock 4173  (8)0 D  
Non-Qualified Stock Option (right to buy) $71.84 6/13/2023  D     7827   (10)9/23/2029 Common Stock 7827  (8)0 D  
Explanation of Responses:
(1) Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 31, 2023, by and among the Issuer, Antech Diagnostics, Inc., a California corporation ("Acquiror"), Helsinki Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Acquiror, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, these shares of performance-based restricted stock of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger.
(2) Pursuant to the Merger Agreement, these performance-based restricted stock units were fully accelerated assuming target level of performance immediately prior to the effectiveness of the merger.
(3) Disposed of pursuant to the Merger Agreement in exchange for cash consideration of $120.00 per share of common stock of the Issuer (the "Merger Consideration") on the effective date of the merger.
(4) Pursuant to the Merger Agreement, these performance shares of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger and canceled in the merger in exchange for an amount in cash equal to $120.00 per share.
(5) 1,500 performance shares previously vested and settled.
(6) Stock options of the Issuer became vested and exercisable upon achieving performance vesting conditions on February 28, 2022.
(7) Pursuant to the Merger Agreement, these stock options of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger.
(8) Stock options of the Issuer were canceled in the merger in exchange for an amount in cash equal to the difference, if any, between the Merger Consideration and the exercise price of such stock options.
(9) These stock options of the Issuer vested in two equal installments on December 31, 2021 and on December 31, 2022.
(10) These stock options of the Issuer vested in three equal installments on September 24, 2020, September 24, 2021 and September 24, 2022.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Sveen Christopher D.
3760 ROCKY MOUNTAIN AVENUE
LOVELAND, CO 80538

CAO & General Counsel
Signatures
/s/ Catherine Grassman For: Christopher Sveen6/13/2023
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Heska (NASDAQ:HSKA)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Heska Charts.
Heska (NASDAQ:HSKA)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Heska Charts.